Comparing the toxicity of two drugs in the framework of spontaneous reporting: a confidence interval approach.
Spontaneous reporting remains the most frequently used technique in post-marketing surveillance. Decision-making usually depends on comparisons between the number of adverse drug reactions (ADRs) reported for two drugs on the basis of an equivalent number of prescriptions. The validity of such comparisons is expected to be jeopardized by probable underreporting ADR cases. This problem is accentuated when it cannot be assumed that the magnitude of underreporting is the same for the both drugs. Differences in reporting ratios can overemphasize, cancel, or reverse the conclusions of a statistical comparison based on the number of reports. We propose a single method for (1) calculating confidence intervals for relative risks estimated in the context of spontaneous reporting and (2) deriving the range of reporting ratios for which the conclusion of the statistical comparison remains statistically valid.
Tubert-Bitter
P
P
Inserm U169, 16 Avenue Paul Vaillant Couturier, 94807 Villejuif, France.
Begaud
B
B
Moride
Y
Y
Chaslerie
A
A
Haramburu
F
F
D016907:Adverse Drug Reaction Reporting Systems; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D004008:Diclofenac / Q000009:adverse effects*; D006801:Humans; D017891:Pharmacoepidemiology / Q000379:methods; D010894:Piroxicam / Q000009:adverse effects*; D016012:Poisson Distribution; D011358:Product Surveillance, Postmarketing
D000894:Anti-Inflammatory Agents, Non-Steroidal; D010894:Piroxicam; D004008:Diclofenac